Levonorgestrel (Jaydess, Skyla, BAY86-5028)
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Intrauterine Devices, Medicated
Conditions
Intrauterine Devices, Medicated
Trial Timeline
Sep 8, 2016 → Dec 23, 2017
NCT ID
NCT02903888About Levonorgestrel (Jaydess, Skyla, BAY86-5028)
Levonorgestrel (Jaydess, Skyla, BAY86-5028) is a pre-clinical stage product being developed by Bayer for Intrauterine Devices, Medicated. The current trial status is completed. This product is registered under clinical trial identifier NCT02903888. Target conditions include Intrauterine Devices, Medicated.
What happened to similar drugs?
1 of 1 similar drugs in Intrauterine Devices, Medicated were approved
Approved (1) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02349815 | Pre-clinical | Completed |
| NCT02903888 | Pre-clinical | Completed |
Competing Products
2 competing products in Intrauterine Devices, Medicated
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mirena (BAY86-5028) | Bayer | Approved | 40 |
| Low-dose levonorgestrel intrauterine systems (LNG-IUS) | Bayer | Pre-clinical | 23 |